BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 20857871)

  • 1. The injection of hypocretin-1 into the nucleus pontis oralis induces either active sleep or wakefulness depending on the behavioral state when it is administered.
    Xi M; Chase MH
    Sleep; 2010 Sep; 33(9):1236-43. PubMed ID: 20857871
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of active (REM) sleep and motor inhibition by hypocretin in the nucleus pontis oralis of the cat.
    Xi MC; Fung SJ; Yamuy J; Morales FR; Chase MH
    J Neurophysiol; 2002 Jun; 87(6):2880-8. PubMed ID: 12037191
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuronal mechanisms of active (rapid eye movement) sleep induced by microinjections of hypocretin into the nucleus pontis oralis of the cat.
    Xi MC; Chase MH
    Neuroscience; 2006 Jun; 140(1):335-42. PubMed ID: 16533574
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects on sleep and wakefulness of the injection of hypocretin-1 (orexin-A) into the laterodorsal tegmental nucleus of the cat.
    Xi MC; Morales FR; Chase MH
    Brain Res; 2001 May; 901(1-2):259-64. PubMed ID: 11368975
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Wake-promoting and sleep-suppressing actions of hypocretin (orexin): basal forebrain sites of action.
    España RA; Baldo BA; Kelley AE; Berridge CW
    Neuroscience; 2001; 106(4):699-715. PubMed ID: 11682157
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pontine reticular formation (PnO) administration of hypocretin-1 increases PnO GABA levels and wakefulness.
    Watson CJ; Soto-Calderon H; Lydic R; Baghdoyan HA
    Sleep; 2008 Apr; 31(4):453-64. PubMed ID: 18457232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. State dependency of the effects of microinjection of cholinergic drugs into the nucleus pontis oralis.
    López-Rodríguez F; Kohlmeier K; Morales FR; Chase MH
    Brain Res; 1994 Jun; 649(1-2):271-81. PubMed ID: 7953643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypocretin and GABA interact in the pontine reticular formation to increase wakefulness.
    Brevig HN; Watson CJ; Lydic R; Baghdoyan HA
    Sleep; 2010 Oct; 33(10):1285-93. PubMed ID: 21061850
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sleep-wakefulness effects after microinjections of hypocretin 1 (orexin A) in cholinoceptive areas of the cat oral pontine tegmentum.
    Moreno-Balandrán E; Garzón M; Bódalo C; Reinoso-Suárez F; de Andrés I
    Eur J Neurosci; 2008 Jul; 28(2):331-41. PubMed ID: 18702704
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interactions between GABAergic and cholinergic processes in the nucleus pontis oralis: neuronal mechanisms controlling active (rapid eye movement) sleep and wakefulness.
    Xi MC; Morales FR; Chase MH
    J Neurosci; 2004 Nov; 24(47):10670-8. PubMed ID: 15564583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of wakefulness and inhibition of active (REM) sleep by GABAergic processes in the nucleus pontis oralis.
    Xi MC; Morales FR; Chase MH
    Arch Ital Biol; 2001 Feb; 139(1-2):125-45. PubMed ID: 11256181
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circadian-dependent and circadian-independent behavioral actions of hypocretin/orexin.
    España RA; Plahn S; Berridge CW
    Brain Res; 2002 Jul; 943(2):224-36. PubMed ID: 12101045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypocretinergic facilitation of synaptic activity of neurons in the nucleus pontis oralis of the cat.
    Xi MC; Fung SJ; Yamuy J; Morales FR; Chase MH
    Brain Res; 2003 Jun; 976(2):253-8. PubMed ID: 12763260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intranasal hypocretin-1: making sense of scents?
    Lammers GJ
    Sleep Med; 2011 Dec; 12(10):939-40. PubMed ID: 22136855
    [No Abstract]   [Full Text] [Related]  

  • 15. A GABAergic pontine reticular system is involved in the control of wakefulness and sleep.
    Xi MC; Morales FR; Chase MH
    Sleep Res Online; 1999; 2(2):43-8. PubMed ID: 11382881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systemic administration of hypocretin-1 reduces cataplexy and normalizes sleep and waking durations in narcoleptic dogs.
    John J; Wu MF; Siegel JM
    Sleep Res Online; 2000; 3(1):23-8. PubMed ID: 11382896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simultaneous pontine and basal forebrain microinjections of carbachol suppress REM sleep.
    Baghdoyan HA; Spotts JL; Snyder SG
    J Neurosci; 1993 Jan; 13(1):229-42. PubMed ID: 8423470
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypocretinergic and non-hypocretinergic projections from the hypothalamus to the REM sleep executive area of the pons.
    Torterolo P; Sampogna S; Chase MH
    Brain Res; 2013 Jan; 1491():68-77. PubMed ID: 23122879
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interactions between hypocretinergic and GABAergic systems in the control of activity of neurons in the cat pontine reticular formation.
    Xi M; Fung SJ; Yamuy J; Chase MH
    Neuroscience; 2015 Jul; 298():190-9. PubMed ID: 25892701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The motor inhibitory system operating during active sleep is tonically suppressed by GABAergic mechanisms during other states.
    Xi MC; Morales FR; Chase MH
    J Neurophysiol; 2001 Oct; 86(4):1908-15. PubMed ID: 11600650
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.